‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year

AI Summary

A life-saving drug for opioid dependency heavily subsidized in Australia will be withdrawn by the end of the year. The US pharmaceutical company Indivior has announced that the long-acting injectable prescription opioid Sublocade will cease marketing and sales due to a commercial decision, raising concerns among Australian medical professionals.

Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration Get our breaking news email, free app or daily news podcast A “life-saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists. US pharmaceutical company Indivior confirmed the marketing and sale of the long-acting injectable prescription opioid Sublocade would end from 31 December, with a company spokesperson describing it as a “commercial decision”. Continue reading...